Literature DB >> 22144496

History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium.

Marni Stott-Miller1, Chu Chen, Shu-Chun Chuang, Yuan-Chin Amy Lee, Stefania Boccia, Hermann Brenner, Gabriela Cadoni, Luigino Dal Maso, Carlo La Vecchia, Philip Lazarus, Fabio Levi, Keitaro Matsuo, Hal Morgenstern, Heiko Müller, Joshua Muscat, Andrew F Olshan, Mark P Purdue, Diego Serraino, Thomas L Vaughan, Zuo-Feng Zhang, Paolo Boffetta, Mia Hashibe, Stephen M Schwartz.   

Abstract

BACKGROUND: A history of diabetes is associated with an increased risk of several types of cancers. Whether diabetes is a risk factor for head and neck cancer (HNC) has received little attention.
METHODS: We pooled data from 12 case-control studies including 6,448 cases and 13,747 controls, and estimated OR and 95% CI for the associations between diabetes and HNC, adjusted for age, education level, sex, race/ethnicity, study center, cigarette smoking, alcohol use, and body mass index.
RESULTS: We observed a weak association between diabetes and the incidence of HNC overall (OR, 1.09; 95% CI: 0.95-1.24). However, we observed a modest association among never smokers (OR, 1.59; 95% CI: 1.22-2.07), and no association among ever smokers (OR, 0.96; 95% CI: 0.83-1.11); likelihood ratio test for interaction P = 0.001.
CONCLUSION: A history of diabetes was weakly associated with HNC overall, but we observed evidence of effect modification by smoking status, with a positive association among those who never smoked cigarettes. IMPACT: This study suggests that glucose metabolism abnormalities may be a HNC risk factor in subgroups of the population. Prospective studies incorporating biomarkers are needed to improve our understanding of the relationship between diabetes and HNC risk, possibly providing new strategies in the prevention of HNC. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 22144496      PMCID: PMC3275674          DOI: 10.1158/1055-9965.EPI-11-0590

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  55 in total

1.  Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.

Authors:  L Wideroff; G Gridley; L Mellemkjaer; W H Chow; M Linet; S Keehn; K Borch-Johnsen; J H Olsen
Journal:  J Natl Cancer Inst       Date:  1997-09-17       Impact factor: 13.506

2.  Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy.

Authors:  S Franceschi; R Talamini; S Barra; A E Barón; E Negri; E Bidoli; D Serraino; C La Vecchia
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

3.  Weight change and diabetes incidence: findings from a national cohort of US adults.

Authors:  E S Ford; D F Williamson; S Liu
Journal:  Am J Epidemiol       Date:  1997-08-01       Impact factor: 4.897

Review 4.  Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor.

Authors:  Timothy E Adams; Neil M McKern; Colin W Ward
Journal:  Growth Factors       Date:  2004-06       Impact factor: 2.511

Review 5.  Occurrence of oral leukoplakia and lichen planus in diabetes mellitus.

Authors:  M Albrecht; J Bánóczy; E Dinya; G Tamás
Journal:  J Oral Pathol Med       Date:  1992-09       Impact factor: 4.253

6.  Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects.

Authors:  P Arner; T Pollare; H Lithell
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

7.  A comparison of the joint effects of alcohol and smoking on the risk of cancer across sites in the upper aerodigestive tract.

Authors:  A E Barón; S Franceschi; S Barra; R Talamini; C La Vecchia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1993 Nov-Dec       Impact factor: 4.254

Review 8.  Mitochondrial diabetes: molecular mechanisms and clinical presentation.

Authors:  J Antonie Maassen; Leen M 'T Hart; Einar Van Essen; Rob J Heine; Giel Nijpels; Roshan S Jahangir Tafrechi; Anton K Raap; George M C Janssen; Herman H P J Lemkes
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

Review 9.  Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

Authors:  Giuseppina Basta; Ann Marie Schmidt; Raffaele De Caterina
Journal:  Cardiovasc Res       Date:  2004-09-01       Impact factor: 10.787

10.  Clinical risk factors of oral leukoplakia in a representative sample of the US population.

Authors:  Thomas Dietrich; Peter A Reichart; Christian Scheifele
Journal:  Oral Oncol       Date:  2004-02       Impact factor: 5.337

View more
  14 in total

1.  [Diabetes mellitus as a prognostic marker in oropharyngeal and laryngeal squamous cell carcinoma].

Authors:  K Zaoui; J Doll; P Stiebi; P Federspil; P K Plinkert; J Hess
Journal:  HNO       Date:  2016-07       Impact factor: 1.284

2.  Incidence and predictors of febrile neutropenia during chemotherapy in patients with head and neck cancer.

Authors:  Yukinori Takenaka; Hironori Cho; Masashi Yamamoto; Susumu Nakahara; Yoshifumi Yamamoto; Hidenori Inohara
Journal:  Support Care Cancer       Date:  2013-06-08       Impact factor: 3.603

3.  Metabolic disorders and the risk of head and neck cancer: a protocol for a systematic review and meta-analysis.

Authors:  Alexander Gormley; Charlotte Richards; Francesca Spiga; Emily Gray; Joanna Hooper; Barry Main; Emma E Vincent; Rebecca Richmond; Julian Higgins; Mark Gormley
Journal:  BMJ Open       Date:  2022-05-04       Impact factor: 3.006

Review 4.  A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism.

Authors:  G Cadoni; S Boccia; L Petrelli; P Di Giannantonio; D Arzani; A Giorgio; E De Feo; M Pandolfini; P Gallì; G Paludetti; G Ricciardi
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-02       Impact factor: 2.124

5.  Association between phosphorylated AMP-activated protein kinase and acetyl-CoA carboxylase expression and outcome in patients with squamous cell carcinoma of the head and neck.

Authors:  Ying-Wen Su; Yun-Ho Lin; Man-Hui Pai; An-Chi Lo; Yu-Chieh Lee; I-Chih Fang; Johnson Lin; Ruey-Kuen Hsieh; Yi-Fang Chang; Chi-Long Chen
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

6.  Diabetes, prediabetes and the survival of nasopharyngeal carcinoma: a study of 5,860 patients.

Authors:  Pu-Yun OuYang; Zhen Su; Jie Tang; Xiao-Wen Lan; Yan-Ping Mao; Wuguo Deng; Fang-Yun Xie
Journal:  PLoS One       Date:  2014-10-28       Impact factor: 3.240

7.  Combined submandibular gland flap and sternocleidomastoid musculocutaneous flap for postoperative reconstruction in older aged patients with oral cavity and oropharyngeal cancers.

Authors:  Xiangmin Zhang; Folin Liu; Xiaolin Lan; Keqing Luo; Shaojin Li
Journal:  World J Surg Oncol       Date:  2014-08-15       Impact factor: 2.754

8.  Prognostic value of Diabetes in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy.

Authors:  Hao Peng; Lei Chen; Yuan Zhang; Wen-Fei Li; Yan-Ping Mao; Fan Zhang; Rui Guo; Li-Zhi Liu; Ai-Hua Lin; Ying Sun; Jun Ma
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

Review 9.  CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis.

Authors:  Jakob Starup-Linde; Oystein Karlstad; Stine Aistrup Eriksen; Peter Vestergaard; Heleen K Bronsveld; Frank de Vries; Morten Andersen; Anssi Auvinen; Jari Haukka; Vidar Hjellvik; Marloes T Bazelier; Anthonius de Boer; Kari Furu; Marie L De Bruin
Journal:  Curr Drug Saf       Date:  2013-11

10.  Screening for dysglycaemia in dental primary care practice settings: systematic review of the evidence.

Authors:  Ingrid Glurich; Barbara Bartkowiak; Richard L Berg; Amit Acharya
Journal:  Int Dent J       Date:  2018-05-08       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.